GlassScriptPhysician profile
Cynthia A Golomb
NPI 1619900388
$9,534.21
in general payments reported to CMS, 2019-2025
29 companies · $2,259 in 2025
The $2,259 reported for 2025 was more than what 79% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $685 · 2021: $570 · 2022: $1,229 · 2023: $1,546 · 2024: $2,548 · 2025: $2,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,245 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $974 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,244.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $974.35 |
| Education | $133.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,356.41 | 2022-2025 | |
| Genzyme Corporation | $1,179.90 | 2020-2025 | |
| Allergan, INC. | $1,085.82 | 2019-2022 | |
| Revance Therapeutics, INC. | $805.78 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $782.03 | 2020-2025 | Nemluvio, Aklief, Dysport |
| Janssen Biotech, INC. | $659.33 | 2020-2025 | Tremfya |
| Pfizer INC. | $551.60 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $446.87 | 2019-2025 | Dupixent |
| Incyte Corporation | $329.33 | 2021-2025 | Opzelura |
| Lilly USA, LLC | $214.73 | 2019-2025 | Taltz, Ebglyss |
| Amgen INC. | $145.05 | 2020-2024 | Otezla |
| Hill Dermaceuticals, INC. | $119.58 | 2023 | Tolak |
| Idorsia Pharmaceuticals US INC | $119.23 | 2024 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $104.07 | 2023-2024 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $102.81 | 2019-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $85.33 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.78 | 2023-2025 | Spevigo |
| Organon LLC | $78.97 | 2025 | Nexplanon |
| Leo Pharma INC. | $48.42 | 2020-2025 | Adbry |
| Merz North America, INC. | $47.75 | 2020-2023 | Xeomin |
| Ucb, INC. | $36.55 | 2022-2025 | Bimzelx |
| Vyne Pharmaceuticals INC. | $26.64 | 2020 | |
| Aclaris Therapeutics, INC. | $23.90 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.84 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $23.17 | 2023 | |
| Dermira, INC. | $17.83 | 2021 | |
| Arcutis Biotherapeutics, INC. | $17.42 | 2024 | Zoryve |
| Pierre Fabre Pharmaceuticals, INC. | $16.16 | 2019 | |
| Mayne Pharma Commercial LLC | $5.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Golomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.